Full-Time

Lead – Program Management

Program Manager

Confirmed live in the last 24 hours

Amylyx Pharmaceuticals

Amylyx Pharmaceuticals

201-500 employees

Develops treatments for neurodegenerative diseases

Biotechnology
Healthcare

Senior

Cambridge, MA, USA

Must reside and work within the United States, in a state where Amylyx currently does business.

Category
Project Management
Business & Strategy
Requirements
  • MS or BS Degree in a Scientific or related field
  • Minimum of 10 years of experience in pharmaceutical or biotechnology drug development with at least 4 years in a project/program management role.
  • Experience with clinical development phases is mandatory.
  • Must have previous experience (at least 2 years) working in a biotech or small pharma
  • Expertise in project management and supporting cross-functional teams with strong organizational skills.
  • Proficiency in project management software and tools (e.g. Smartsheet, MS Project, Sharepoint or similar).
  • Project Management Professional (PMP) or equivalent project/program management certification is highly desirable.
  • Excellent written and verbal communication.
  • Exceptional communication and interpersonal skills.
  • Extremely well-organized with the ability to manage multiple programs with highly detailed workflows.
  • Self-motivated with expertise in both planning and implementation.
  • Enthusiasm for working in a fast-paced dynamic environment with a sense of urgency.
Responsibilities
  • Building and maintaining complex program plans that include scope, timelines, milestones, deliverables, key Go/No-Go decision points, resources and budgets.
  • Managing multiple cross-functional teams and meetings including scheduling, agendas, minutes, and actions.
  • Ensuring effective and timely communication to team members and senior leadership regarding program status, key milestones, identified risks and resource allocation. Includes generating monthly program reports/dashboards as well as assisting with portfolio level documents.
  • Assisting with identification of strategic or operational issues impacting plan execution and working with the team to identify risks and develop mitigation strategies.
  • Proactively identify, articulate, escalate and manage program risks; collaborate with key stakeholders to recommend constructive solutions.
  • Supporting the development and application of Project Management tools, templates, and best practices.
Amylyx Pharmaceuticals

Amylyx Pharmaceuticals

View

Amylyx Pharmaceuticals develops treatments for neurodegenerative diseases, focusing on conditions like Amyotrophic Lateral Sclerosis (ALS) and Alzheimer's Disease (ALZ). Their main product, AMX0035, is currently undergoing clinical trials, including the CENTAUR ALS trial, which showed significant benefits for ALS patients through a randomized, double-blind, placebo-controlled study. They are also conducting the PEGASUS trial to assess AMX0035's safety and effectiveness for Alzheimer's patients. Unlike many competitors, Amylyx emphasizes community engagement and awareness campaigns, such as ALS Awareness Month, to educate the public and foster support for those affected by these diseases. The company's goal is to bring effective therapies to market that improve patient outcomes.

Company Stage

IPO

Total Funding

$166.7M

Headquarters

Cambridge, Massachusetts

Founded

2013

Growth & Insights
Headcount

6 month growth

-38%

1 year growth

-33%

2 year growth

1%
Simplify Jobs

Simplify's Take

What believers are saying

  • Successful acquisition of Phase 3-ready avexitide from Eiger could diversify Amylyx's pipeline and open new revenue streams.
  • Interim data from the Phase 2 HELIOS trial shows promising results for AMX0035 in treating Wolfram syndrome, indicating potential for broader applications.
  • The appointment of experienced professionals like Dr. Bernhardt Zeiher to the Board of Directors strengthens the company's leadership and strategic direction.

What critics are saying

  • The failure of the Phase III PHOENIX trial and subsequent market withdrawal of Relyvrio raises concerns about the efficacy of Amylyx's treatments.
  • A significant workforce reduction by 70% under a restructuring plan could impact company morale and operational efficiency.

What makes Amylyx Pharmaceuticals unique

  • Amylyx Pharmaceuticals focuses on neurodegenerative diseases like ALS and Alzheimer's, setting it apart from competitors with broader therapeutic areas.
  • The company's flagship product, AMX0035, has shown significant treatment benefits in rigorous clinical trials, including the CENTAUR ALS trial, which is a strong validation of its efficacy.
  • Amylyx's commitment to community engagement and awareness campaigns, such as ALS Awareness Month, enhances its brand and builds a supportive community around its cause.

Help us improve and share your feedback! Did you find this helpful?